← All companies

Ginkgo Bioworks

Technology

Company overview

Ginkgo Bioworks designs microbes and bacteria for industrial use through genetic engineering. Its Build Your Own Lab offering gives customers hardware and software to build automated labs. Its Cloud Lab service lets customers run experiments remotely on Ginkgo's automated lab in Boston. Ginkgo Solutions offers custom project design and experiment services for pharmaceutical and biotech customers such as Novartis, Pfizer, Bayer, and Biogen. The company is based in Boston, Massachusetts.

Five MIT scientists, Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton, and Austin Che, founded Ginkgo Bioworks in 2008. The company went public on the NYSE under the ticker DNA through a SPAC merger on September 17, 2021. It grew from a small group of scientists into a public company that serves more than 130 customers, so people who join work alongside both lab scientists and software engineers. Ginkgo Bioworks is a top-tier H-1B sponsor.

Industry
Technology
Headquarters
Boston, United States

Filters

Create your account

Create an account to save jobs and track applications.